MiramarLab 2025-12-18 Health moderate CPSC
Health · CPSC · Recall #CPSC-26157
Mamisan Pain Relieving Topical Ointment Recall
Issued December 18, 2025 · MiramarLab · 50,330 units affected
In December 2025, MiramarLab recalled the Mamisan Pain Relieving Topical Ointment, a moderate health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
What you should do
- 1 Keep using Mamisan Pain Relieving Topical Ointment only as advised. See the remedy below.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact MiramarLab to arrange your repair. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Repair): Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Recall details
- Brand
- MiramarLab
- Category
- Health
- Recall date
- December 18, 2025
- Units affected
- 50,330
- Sold at
- Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
- Recall number
- CPSC-26157
- Made in
- United States
- Issuing agency
- CPSC
In context
- MiramarLab has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 50,330 units is enough to reach roughly 1 in every 2,603 US households.
- This is the 691st Health recall we've logged in 2025.